SCHEMBL6300841

SCHEMBL6300841

OC(CNc1nc(Cl)cc(Cl)n1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
CYP2D6 P10635 1/20 0.50
FAAH O00519 3/20 0.48
HPGD P15428 1/20 0.48
MAPK1 P28482 1/20 0.48
AOC3 Q16853 3/20 0.47
HTT P42858 1/20 0.47
CTSS P25774 4/20 0.46
CTSK P43235 4/20 0.46
CTSL P07711 3/20 0.44
CTSB P07858 3/20 0.44
LMNA P02545 2/20 0.44
PLA2G1B P04054 1/20 0.44
POLB P06746 1/20 0.44
ATG4B Q9Y4P1 1/20 0.44
CDK1 P06493 1/20 0.43
CDK5 Q00535 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
BCAT2 O15382 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6298554 0.80 CYP2D6 (0.54) KDM4EL3MBTL1CYP2D6FAAHHPGD
SCHEMBL11268852 0.78 CYP2D6 (0.51) KDM4EL3MBTL1CYP2D6FAAHHPGD
SCHEMBL12322194 0.78 HRH4 (0.54) KDM4EL3MBTL1CYP2D6FAAHAOC3
SCHEMBL12322203 0.78 CYP2D6 (0.51) KDM4EL3MBTL1CYP2D6FAAHHPGD
Fenyripol SCHEMBL828783 0.76 CYP2D6 (0.70) KDM4EL3MBTL1CYP2D6FAAHHPGD
SCHEMBL12322218 0.75 FAAH (0.49) KDM4EL3MBTL1CYP2D6FAAHHTT
SCHEMBL11280431 0.75 FAAH (0.49) KDM4EL3MBTL1CYP2D6FAAHHTT
Fenyripol SCHEMBL120829 0.75 CYP2D6 (0.68) KDM4EL3MBTL1CYP2D6FAAHHPGD
SCHEMBL3403712 0.74 FAAH (0.68) CYP2D6FAAH
SCHEMBL3406721 0.74 FAAH (0.68) CYP2D6FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050159437-A1 Pharmaceutical agents JARROTT BEVYN (AU) 2005-07-21 US disclosed
US-6881740-B1 Pharmaceutical agents MONASH UNIVERSITY (AU) 2005-04-19 US disclosed
EP-1095026-A4 PHARMACEUTICAL AGENTS UNIV MONASH (AU) 2001-10-31 EP disclosed
EP-1095026-A1 PHARMACEUTICAL AGENTS MONASH UNIVERSITY (AU) 2001-05-02 EP disclosed
WO-2000002865-A1 PHARMACEUTICAL AGENTS MONASH UNIVERSITY (AU) 2000-01-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050159437-A1 Pharmaceutical agents F12, NAT1, H1-0 KDM4E 3930/4885L3MBTL1 4080/4885CYP2D6 35/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.